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.Abstract  
Background 
The 5-year follow-up results for the 1202 middle-aged men prospective study of CHD 
incidence were published in 1980. This paper extends the follow-up, relating the 
development of CHD to ten risk factors.  
Methods 
The population studied comprised all men born in aged 45-64 years at baseline who were 
registered in six group practices in Belfast. Some 1202 CHD-free men entered the study. 
Study endpoints included: (a) the development of CHD, (b) of myocardial infarction, (c) of 
angina pectoris (d) death from myocardial (d) death from other causes. The men were 
followed for an average of 6.9 years and the influence of ten risk factors was assessed by 
Cox’s proportional hazards model in a competing risk framework. 
Results 
The analysis first major CHD event identified 4 risk factors – diastolic blood pressure, serum 
cholesterol, T wave abnormality and tobacco index. First myocardial depended on diastolic 
blood pressure, ST abnormality and tobacco index, while time to first angina pectoris 
depended on serum cholesterol, T abnormality, tobacco index and age at entry. These 
findings do not support the hypothesis of a common risk factor profile in the myocardial 
infarction and angina pectoris groups. The sensitivity of all models was poor.  
Discussion 
The study confirms the role of known risk factors in the development of first CHD event. It 
also suggests that the risk factors involved in developing myocardial infarction and angina 
pectoris differ.  The poor sensitivity of models suggests the presence of unmeasured risk 
factors in the aetiology of CHD.  
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What is already known about this subject? 
 A great deal of evidence has been adduced by various prospective studies 
conducted in North America and in Northern Europe.  However, there have been 
comparatively few UK-based studies. Classically, these studies have implicated 
elevated serum cholesterol, hypertension, smoking and lack of exercise as being 
among the most important determinants of increased risk of CHD.  
 
What does this study add? 
 
It employs modern statistical survival methods to analyse, in a competing risks 
framework, the variable time incidence data accrued in Belfast, UK. Overall, the 
results are largely consonant with the findings from the mainstream international 
studies. A novel finding is evidence suggesting that the development of myocardial 
infarction and angina pectoris depend of different sets of risk factors. The total 
amount of tobacco smoked is, however, a risk factor in common. The paper is also 
interesting from a historical perspective, as it is a ‘lost’ paper from, John Pemberton, 
one of the founders of our Society.  Accordingly, it is truly a prospective study in the 
past.   
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Introduction 
Greig et al (1980)[1] reported the results of a prospective study of CHD 
conducted among 1202 middle-aged men registered in six group practices in 
Belfast, Northern Ireland, who were followed for five years. This report extends 
that original work to include the analysis of events which occurred in subsequent 
years of follow-up using time to event methods. Although the prospective study is 
now formally closed, 85% have been followed for more than 5.5 years and 39% 
for more than 7.5 years. As in the earlier study the aim is to identify social and 
biological characteristics of middle-aged men which are predictive of the 
development of CHD. 
2. Methods 
These have been described elsewhere.[1] Briefly, the population studied 
comprised all men born in the 10 year period 1909-1918 (that is, those aged 45-
64 years at the beginning of the study) who were registered in six group practices 
in Belfast, Northern Ireland. For the prospective study, men were free from 
angina of effort and free from a confirmed MI at the baseline examination. Some 
1202 men entered and were followed up. Study endpoints included: (a) the 
development of myocardial infarction (MI), (b) the development of angina pectoris 
(AP), (c) death from MI and (d) death from other causes. 
 MI was diagnosed when the subject had typical a history of chest pain and at 
least one of: serial changes in a follow-up ECG, indicative of MI (usually 
Minnesota[2] codes 1-3), or elevated serum enzymes. All diagnoses were made 
by consultant physicians.  Angina of effort was diagnosed according to the criteria 
devised by Rose,[3] as provided for in the study follow-up procedures. Details of 
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the causes of death were obtained from the Registrar General of Northern 
Ireland[4].   
Associated with each of the events was a corresponding ‘time to event’. For 
individuals who developed two or more events, the time to each event was 
recorded. The protocol permitted recurrent episodes of some types of non-fatal 
CHD events to be recorded.  
The follow-up was by annual questionnaires, supplemented by GP visits (by Dr. 
Greig) and referrals to outpatient Departments where the diagnosis of angina 
pectoris or cardiac ischaemia was made by a consultant physician.[1] Information 
on Deaths was obtained from the Northern Ireland Registrar General[4].   
Ten risk factors were studied. They were: diastolic blood pressure (mm Hg), 
height (cm), serum cholesterol (mg/100 ml), lipo-protein ratio (dimensionless), 
skinfold thickness (mm), Q/QS abnormality (present/absent), T wave abnormality 
(present/absent), ST abnormality (present/absent), tobacco index  (lifetime 
grams/365) and age at entry.  These data were complete.  
The standard method of analysing prospective incidence data is based on the 
multiple logistic function[5]. Here, the data, being variable time incidence, were 
analysed within the competing risks framework using Cox’s PH model [6,7] . In 
this approach time is measured from baseline to the development of a CHD-
related event or death. More general methods[8,9] have been developed to deal 
with the analysis of multiple episodes, but the incidence of these events was too 
low to warrant their application. 
Four separate analyses were undertaken: 
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1. Time to first major CHD event, defined as the first of any of the events a) to c) 
above. 
2. Time to first MI defined as the first of either of the events a) or c) , 
3. Time to first AP defined as the first occurrence of event b) above. 
4. A competing risks analysis involving three mutually exclusive endpoints: first 
MI alone, first AP alone, and both conditions together. For individuals who 
developed both, time to the first event was used. 
In all four analyses, individuals who died from other causes were treated as 
censored at their time of death. 
3. Results 
Of the 1202 men followed for an average of 6.9 years, 1047 (87.1%) were 
disease-free and 155 (12.9%) developed CHD.  Among the developers, 52 
(4.3%) developed MI alone, 62 (5.2%) developed AP alone and 41 (3.4%) 
developed both conditions. Among men who developed myocardial infarction, 43 
(3.6%) died.  
The annual incidence rate for first major CHD event rose from a minimum 0.84% 
in the first year of follow-up to a maximum of 3.67% in the  last 10th year. The low 
incidence in the first years suggests that the baseline examination was 
successful in excluding subjects with overt disease. There was a gradual 
increase in the incidence rate over time. These rates are high in comparison with 
other published studies[10].  
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 The relationship between the incidence of the first major event and the ten 
factors was investigated using the PH regression model. As a first step the global 
null hypothesis (β=0) was tested and rejected (2 =47.92, df=10, p<0.001) . Table 
1 details the maximum partial likelihood estimates of the parameters in the PH 
model for: no adjustment, age-adjustment, and full adjustment (10 factors). The 
single factor analysis identified six factors which were individually positively 
associated with developing a major CHD event. Adjustment for age left these 
findings unaltered. However, simultaneous adjustment (final column) identified a 
subset of only four factors: diastolic blood pressure (DBP), serum cholesterol 
(SC), T abnormality and tobacco index (TI). The independent effects of these four 
factors were confirmed using a backwards elimination algorithm (Table 1). The 
magnitude of the effects of SC and TI were similar in the various analyses. 
In relation to first MI the global null hypothesis was again tested and rejected (2 
=20.77, df=10, p<0.05). However, the pattern of contribution from the 10 factors 
studied singly differed from that observed in the previous analysis. In particular, 
the factors T abnormality and SC were not included in the model. Adjustment for 
age made no difference and details of the final 3-factor model which included: 
DBP, ST abnormality and TI are presented in Table 2.  
Similar analyses were repeated for the time to first AP (2 =37.16, df=10, 
p<0.001). The final (Table 3) contained SC, T abnormality, TI and age at entry. 
The absence of DBP and the entry of age at baseline examination should be 
noted (Table 2)..  
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Table 1: Single and Multifactor analyses of factors influencing time to first major CHD-related event: MPL 
estimates and their standard errors (se) from the proportional hazard models. 
 
Factor 
Adjustment 
None Age All 
Estimate se Estimate se Estimate se 
Diastolic Blood Pressure +0.194*           (0.062) +0.195* (0.062) +0.133* (0.065) 
Height -0.076 (0.058) -0.076 (0.060) -0.075 (0.064) 
Cholesterol +0.068* (0.026) +0.073* (0.026) +0.064* (0.027) 
Lipoprotein ratio -0.020 (0.031) -0.018 (0.031) +0.003 (0.033) 
Skinfold thickness +0.025 (0.014) +0.025 (0.014) +0.016 (0.014) 
Q/QS abnormality +0.516 (0.264) +0.542* (0.265) +0.162 (0.278) 
T abnormality +0.947* (0.222) +0.941* (0.222) +0.700* (0.239) 
ST abnormality +0.798* (0.281) +0.789* (0.281) +0.449 (0.298) 
Tobacco index +0.049* (0.018) +0.047* (0.019) +0.052* (0.018) 
Age +0.029 (0.024) - - +0.026 (0.025) 
NB:  (a) * Exceeds 2 standard errors (b) continuous variables were re-scaled (z transformation). 
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Table 2: Final models for CHD-related events and their sub-components: first 
major event, myocardial infarction and angina pectoris: MPL estimates and their 
standard errors.  
Factor Estimate se t 
First Major Event 
Diastolic BP +0.163 (0.061) +2.7 
Cholesterol +0.065 (0.026) +2.6 
T abnormality +0.824 (0.223) +3.7 
Tobacco index +0.052 (0.013) +2.8 
First Myocardial Infarction 
Diastolic BP +0.185 (0.082) +2.3 
ST abnormality +0.772 (0.354) +2.2 
Tobacco index  +0.058 (0.024) +2.4 
First Angina Pectoris 
Cholesterol +0.093 (0.032) +2.9 
T abnormality +0.936 (0.266) +3.5 
Tobacco index +0.044 (0.022) +2.0 
Age +0.064 (0.030) +2.2 
NB: From the proportional hazards models. 
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Table 3: Competing risks analysis: myocardial infarction alone, angina pectoris 
alone and both conditions: MPL estimates and standard errors. 
Factor Estimate se t 
Myocardial Infarction Alone 
Diastolic BP +0.249 (0.012) +2.44 
Angina Pectoris Alone 
Cholesterol +0.096 (0.040) +2.40 
T abnormality +1.074 (0.321) +3.35 
Age  +0.079 (0.037) +2.11 
Both MI and AP 
Tobacco index +0.067 (0.035) 1.91 
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Finally a competing risks analysis was conducted. Table 3 shows the best fitting 
models in each of the three mutually exclusive groups analysed. In the MI alone 
group only DBP was formally statistically significant in multi-factor testing. The 
pattern in AP alone was more clear-cut with three factors identified:  SC, T-
abnormality and age at entry, significantly and positively related to outcome. In 
the subgroup of individuals who developed both conditions, TI was only factor to 
approach statistical significance. Although the numbers involved were small, 
these findings tend not to support the hypothesis that a common set of risk 
factors underpin the development of these two conditions. 
The maximal estimated conditional probability of development of a major CHD 
event was 0.35 for men who were at highest risk. They had above average SC. a 
high DBP (100 mm Hg), smoked a lot (1000+) and had a T abnormality in their 
baseline ECG. By contrast men in the cell with minimum risk had an estimated 
conditional probability of developing of 0.03. Thus, the relative risk of 
development was approximately 11 showing that the risk factors graduated the 
relative risk well. However, regarding strength of association[11], a probability of  
0.35 is not high. Thus, a man in the cell with the maximum risk has more chance 
of not developing CHD over the five-year period (1.00 - 0.35 = 0.65) and   we 
conclude that the PH model is not a good predictor of individual risk. The 
distributions of estimated risk in the developed (a major CHD event) and non-
developed groups were almost completely overlapping on the x-axis (Figure 1).   
The consistency of the Belfast findings was examined by comparing them with the 
results of the Pooling Project,[10] in North America.  Table 4 shows the numbers 
of observed and expected first major CHD events by quintile of expected risk 
based on the 4-factor multiple logistic function in Belfast and the multiple function 
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used in the Pooling Project. In Belfast the uppermost quintile of expected risk 
contained only 36% of the observed CHD events - exactly the same proportion as 
in the Pooling Project. Accordingly, overall, the results were not dissimilar.  
4 Discussion 
We have adopted new approach to the analysis of CHD incidence data. We have 
focussed on identifying risk factors associated with (first major) CHD event 
incidence in a prospective framework and on investigating whether the incidence 
of myocardial infarction and angina pectoris depends on the same set of risk 
factors. It was the proportional hazards regression survival model enabled the 
additional, variable time, follow-up information to be analysed. The use of the 
competing risks framework facilitated the investigation. These flexible methods 
will no doubt see future service in the analysis of longitudinal epidemiological 
data. Study Methods 
Designed in 1963, the present study related measurements made at a single 
examination to the subsequent incidence of CHD among men who satisfied the 
common entry criteria for the prospective study. Accordingly, subsequent risk 
factor modifications, resulting from changes in life-style or from medication, were 
not evaluated. Diagnostic criteria for the surveillance of CHD-related events were 
modelled largely, but not exclusively, on contemporary American studies such as 
those conducted in Albany,[12] Los Angeles[13] and Framingham[14] thus 
permitting broad comparisons with many published series, especially in relation 
to myocardial infarction (c) Findings 
Like many previous studies employing similar methods this study has shown that 
the risk of developing CHD was significantly related to a number of factors: SC, 
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DBP, T abnormality and TI. These results are broadly to similar to those 
presented in the final report of the Pooling Project which, however, excluded men 
who had definite ECG evidence of myocardial infarction, irrespective of history.   
The analysis of component subgroups for first major event seemed mandatory 
since these sub-groups may contain valuable aetiological clues about the 
underlying disease process.   Although the numbers involved are relatively small, 
any orthodox interpretation of the findings suggests that the incidences of first MI 
and first AP depended on different sets of risk factors. A common factor was TI, a 
finding also suggested by the competing risks analysis. 
Overall, these results tend to support modern theories of pathogensis.[15]  In the 
case of AP, the process appears consistent with chronic atherogenesis  
associated with elevated SC and increased tobacco consumption among older 
men who presented with evidence of ischaemia at initial examination. By contrast, 
for men in the myocardial infarction group the findings are consistent with a more 
acute process based, perhaps, on repeated haemodynamic stress resulting in 
increased thrombolytic activity. 
Prospective studies of coronary events are limited in the information they supply 
and are seldom uniform with regard to methods employed. The relatively weak 
associations found here suggest that there are other, as yet unidentified, risk 
factors in play. The competing risks approach, found useful in this study, is 
relatively novel and so more detailed comparisons with other work are difficult 
[16].  
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Table 4: Comparison of numbers of first major CHD events by quintile of 
estimated risk in the 1202 men study in Belfast and in the Pooling Project. 
Quintile of  
Estimated risk 
Belfast Pooling Project 
Obs Exp Obs Exp 
 
I 5 10.5 21 21.2 
II 15 14.8 27 29.8 
III 15 17.1 39 38.1 
IV 32 23.4 52 49.2 
V 37 37.7 75 76.1 
 
V/(I+II) 1.9 1.5 1.6 1.5 
% in V 36 36 36 35 
NB: I =lowest risk,…,V=highest risk 
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5. Conclusions 
Three decades of epidemiological research have identified associations between 
a number of risk factors and CHD. While these associations appear to satisfy 
many of Bradford Hill’s criteria for causality[11] and can be regarded as having 
aetiological significance, they are nevertheless weak.  The most succinct 
summary in shown in Figure 1 – important risk factors would have produced more 
separation. Perhaps such figures should be included routinely in the results 
sections of prospective studies as they quantify, forcefully, the magnitude of the 
identification task outstanding.   
The Belfast study suggests that different sets of risk factors underpin the 
development of MI and AP. Another novel finding is the identification of a ST-
abnormality in the baseline ECG for MI. However, the study confirms the poor 
sensitivity and specificity encountered in other studies[10].  The implications for 
prediction for screening strategies have been discussed thoroughly elsewhere. 
[17-19] 
Accordingly, either the final pathway by which existing risk factors co-operate to 
produce the disease is poorly understood (or poorly measured in this study) or 
there are other risk factors which remain to be discovered.  This accounts, at least 
in part, for over-optimism about the usefulness of recent population-based multi-
factor primary intervention studies.[20-22] 
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